Profile
Sandford Sommer is currently the President & Chief Operating Officer at Ligand UK Ltd.
He previously worked as the Director at UK Colombia Trade and as the President-Colombia operations at AstraZeneca PLC.
Sandford Sommer active positions
| Companies | Position | Start |
|---|---|---|
| VERNALIS | President | 2016-04-30 |
Former positions of Sandford Sommer
| Companies | Position | End |
|---|---|---|
| UK Colombia Trade | Director/Board Member | - |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| Private companies | 2 |
|---|---|
Ligand UK Ltd.
 Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1986 and is headquartered in Winnersh, the United Kingdom. | Health Technology |
| UK Colombia Trade |
- Stock Market
- Insiders
- Sandford Sommer
